Skip to main content
. 2021 Sep 29;11:97. doi: 10.1186/s13550-021-00840-4

Fig. 2.

Fig. 2

a, b Representative BLI images of mice injected with MM.1S-CG and U266-CG cells, respectively (treated and untreated cohorts), showing systemic tumor progression and response to bortezomib therapy over time. c, d Percent increase in bioluminescence signal intensity showing tumor progression in treated and untreated cohorts plotted as a function of time (weeks post-tumor implantation)